本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Altimmune, Inc.

4.85
+0.06001.25%
盘后4.850.00000.00%16:45 EDT
成交量:180.28万
成交额:865.30万
市值:3.74亿
市盈率:-3.62
高:4.94
开:4.88
低:4.71
收:4.79
数据加载中...
2022/03/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/17

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/12/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

重要事件披露

8-K - Current report
2021/09/24

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股变动声明

4 - Statement of changes in beneficial ownership of securities